Suchergebnisse - "Incorvaia, Lorena"

PubPharm (136)

1

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

2

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

3

Prevention of post-contrast kidney injury in patients with cancer

enthalten in: Drugs in context | 2024

von Grassedonio, E. | Incorvaia, L. | Guarneri, M. | +2

4

On-treatment dynamics of circulating extracellular vesicles (EVs) in the first-line setting of patients with advanced non-small cell lung cancer (NSCLC): the LEXOVE prospective study

enthalten in: ResearchSquare.com | 2024

von GRISTINA, V. | Bazan, V. | Barraco, N. | +14

5

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors : a meta-analysis

enthalten in: Frontiers in cardiovascular medicine | 2024

von Inno, A. | Veccia, A. | Madonia, G. | +6

6

KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs) : Results From a Multi-Institutional Cohort Study

enthalten in: The oncologist | 2024

von Incorvaia, L. | De Biase, D. | Nannini, M. | +22

7

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations : Differential Effectiveness by Risk Group?

enthalten in: European urology oncology | 2024

von Santoni, M. | Buti, S. | Myint, Z. | +63

8

Mapping the landscape of immunonutrition and cancer research : a comprehensive bibliometric analysis on behalf of NutriOnc Research Group

enthalten in: International journal of surgery (London, England) | 2024

von De Felice, F. | Cattaneo, C. | Poto, G. | +15

9

Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors : Still looking through a dirty glass window?

enthalten in: Cancer treatment reviews | 2023

von Incorvaia, L. | Perez, A. | Marchetti, C. | +21

10

A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)

enthalten in: European journal of radiology open | 2023

von Cappello, G. | Giannini, V. | Cannella, R. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]